Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Fluvoxamine products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 10, 2026.
An SSRI antidepressant used to treat obsessive-compulsive disorder and depression.
Products affected
1 / 10
In shortage since
May 6, 2026
Est. full return
Aug 10, 2026
Reports on file
46
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-FLUVOXAMINE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02255529 · since May 6, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Resolved
LUVOX
50MG · TABLET · BGP PHARMA ULC
DIN 01919342 · ended Jan 21, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVOXAMINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02255537 · ended Jan 20, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-FLUVOXAMINE
100MG · TABLET · APOTEX INC
DIN 02231330 · ended May 16, 2024 · Disruption of the manufacture of the drug.
Resolved
ACT FLUVOXAMINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02255537 · ended May 8, 2024 · Disruption of the manufacture of the drug.
Resolved
ACT FLUVOXAMINE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02255529 · ended Mar 6, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FLUVOXAMINE
100MG · TABLET · APOTEX INC
DIN 02231330 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Resolved
LUVOX
50MG · TABLET · BGP PHARMA ULC
DIN 01919342 · ended Jan 9, 2024 · Disruption of the manufacture of the drug.
Resolved
ACT FLUVOXAMINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02255537 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.
Discontinued
FLUVOXAMINE-100
100MG · TABLET · PRO DOC LIMITEE
DIN 02236754
Discontinued
FLUVOXAMINE-50
50MG · TABLET · PRO DOC LIMITEE
DIN 02236753
Resolved
APO-FLUVOXAMINE
50MG · TABLET · APOTEX INC
DIN 02231329 · ended Jul 26, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 46 reports. All reports are on file with Health Canada.
What's happening
Fluvoxamine is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Fluvoxamine is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
No changes recorded yet.
Common questions
What is Fluvoxamine used for?
An SSRI antidepressant used to treat obsessive-compulsive disorder and depression.
When will Fluvoxamine be back in stock in Canada?
The latest manufacturer estimate is Aug 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Fluvoxamine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.